Idexx Laboratories, Inc. logo

Idexx Laboratories, Inc. (IX1)

Market Open
3 Jun, 06:03
447. 60
+2.5
+0.56%
- Market Cap
55.21 P/E Ratio
0% Div Yield
0 Volume
9.84 Eps
445.1
Previous Close
Day Range
447.6 447.6
Year Range
325.2 473.5
Earnings results expected in 62 days

Summary

IX1 trading today higher at €447.6, an increase of 0.56% from yesterday's close, completing a monthly increase of 8.67% or €35.7. Over the past 12 months, IX1 stock gained 12.49%.
IX1 is not paying dividends to its shareholders.
The last earnings report, released on Apr 29, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Aug 04, 2025.
Idexx Laboratories, Inc. has completed 1 stock splits, with the recent split occurring on Jun 16, 2015.
The company's stock is traded on 10 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).
Want to track IX1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

IX1 Chart

Chart

Empty chart
The chart has 2 Y axes displaying values, and values.
Loading, please wait...
End of interactive chart.
IDEXX Laboratories: Growth Remains Despite Weak Clinical Visits

IDEXX Laboratories: Growth Remains Despite Weak Clinical Visits

IDEXX Laboratories, Inc. delivered strong Q1 FY25 results with 4.7% organic revenue and 7% adjusted EPS growth, despite weak US clinical visits. I see catalysts ahead: potential U.S. tax cuts, normalization of consumer spending, and robust pricing power supporting profit growth. Management guides for 6%-9% organic revenue and 8%-12% adjusted EPS growth in FY25; I model 8.2% revenue growth and margin expansion.

Seekingalpha | 2 weeks ago
Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year?

Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year?

Here is how Idexx Laboratories (IDXX) and AngioDynamics (ANGO) have performed compared to their sector so far this year.

Zacks | 2 weeks ago
Compared to Estimates, Idexx (IDXX) Q1 Earnings: A Look at Key Metrics

Compared to Estimates, Idexx (IDXX) Q1 Earnings: A Look at Key Metrics

Although the revenue and EPS for Idexx (IDXX) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks | 1 month ago

Idexx Laboratories, Inc. Dividends

IX1 is not paying dividends to its shareholders.

Idexx Laboratories, Inc. Earnings

4 Aug 2025 (62 Days) Date
-
Cons. EPS
-
EPS
29 Apr 2025 Date
-
Cons. EPS
-
EPS
3 Feb 2025 Date
-
Cons. EPS
-
EPS
31 Oct 2024 Date
-
Cons. EPS
-
EPS
30 Oct 2024 Date
-
Cons. EPS
-
EPS
IX1 is not paying dividends to its shareholders.
4 Aug 2025 (62 Days) Date
-
Cons. EPS
-
EPS
29 Apr 2025 Date
-
Cons. EPS
-
EPS
3 Feb 2025 Date
-
Cons. EPS
-
EPS
31 Oct 2024 Date
-
Cons. EPS
-
EPS
30 Oct 2024 Date
-
Cons. EPS
-
EPS

Idexx Laboratories, Inc. (IX1) FAQ

What is the stock price today?

The current price is €447.60.

On which exchange is it traded?

Idexx Laboratories, Inc. is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is IX1.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 0.

When is the next earnings date?

The next earnings report will release on Aug 04, 2025.

Has Idexx Laboratories, Inc. ever had a stock split?

Idexx Laboratories, Inc. had 1 splits and the recent split was on Jun 16, 2015.

Idexx Laboratories, Inc. Profile

Medical - Diagnostics & Research Industry
Healthcare Sector
Mr. Jonathan J. Mazelsky CEO
XFRA Exchange
US45168D1046 ISIN
US Country
11,000 Employees
- Last Dividend
16 Jun 2015 Last Split
21 Jun 1991 IPO Date

Overview

IDEXX Laboratories, Inc., established in 1983 with its headquarters in Westbrook, Maine, is a global leader in the development, manufacturing, and distribution of a broad range of products for various markets including companion animal veterinary, livestock and poultry, dairy, and water testing. With its operations stretching from Africa, the Asia Pacific, Canada, Europe, to Latin America and beyond, IDEXX focuses on enhancing the health and well-being of pets, people, and livestock around the world. The company operates through three distinct segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry, and Dairy. IDEXX's commitment to innovation and quality is evident in its comprehensive product offerings and services, which cater to the diagnostic and health-monitoring needs of these fields.

Products and Services

  • Companion Animal Products:

    Includes a wide range of veterinary diagnostic products such as instruments, consumables, rapid assay test kits, veterinary reference laboratory diagnostic and consulting services, practice management and diagnostic imaging systems. These offerings support veterinarians in delivering high-quality care to companion animals.

  • Livestock, Poultry, and Dairy Products:

    Provides diagnostic and health-monitoring products for the livestock, poultry, and dairy sectors. These products are designed to enhance productivity and health in these industries, ensuring the well-being of animals and the safety of food products.

  • Water Quality Products:

    Offers solutions for the detection of various microbiological contaminants in water. Products like Colilert, Colilert-18, and Colisure tests are developed for quick and accurate detection of total coliforms and E. coli, among other water quality testing solutions.

  • Veterinary Software and Services:

    Provides an array of veterinary software and services that support independent veterinary clinics and corporate groups in managing their operations more efficiently, thereby enhancing patient care and business outcomes.

  • Biomedical Research Products and Services:

    Offers health monitoring, biological materials testing, and laboratory diagnostic instruments and services catering to the biomedical research community. These products support research and development activities in life sciences.

  • Human Medical Products:

    Although primarily focused on animal health, IDEXX also extends its expertise to human medical point-of-care products and laboratory diagnostics services, thereby contributing to the broader field of healthcare.

Contact Information

Address: One IDEXX Drive
Phone: 207 556 0300